Int Immunopharmacol:商陆皂苷甲或能治疗神经炎性疾病

2017-08-29 MedSci MedSci原创

商陆(Phytolacca esculenta),为商陆科植物商陆Phytolacca acinosa Roxb.或垂序商陆Phytolacca americana L.的干燥根。具有逐水消肿,通利二便之功效,外用具有解毒散结之功效。常用于水肿胀满,二便不通;外治痈肿疮毒。商陆皂苷甲(EsA)是一个从商陆根中分离出的皂苷。既往的研究发现,EsA可能对类风湿性关节炎、肾小球肾炎、自身免疫疾病等炎症性

商陆(Phytolacca esculenta),为商陆科植物商陆Phytolacca acinosa Roxb.或垂序商陆Phytolacca americana L.的干燥根。具有逐水消肿,通利二便之功效,外用具有解毒散结之功效。常用于水肿胀满,二便不通;外治痈肿疮毒。

商陆皂苷甲(EsA)是一个从商陆根中分离出的皂苷。既往的研究发现,EsA可能对类风湿性关节炎、肾小球肾炎、自身免疫疾病等炎症性疾病有益。那商陆皂苷甲是否也对神经炎性疾病有效?

本研究的目的是探讨EsA对脂多糖(LPS)预处理的BV2小神经胶质细胞和原代培养的小胶质细胞的药理作用。

研究结果表明,在BV2小胶质细胞和原代培养的小胶质细胞中,EsA预处理能显著降低LPS诱导的一氧化氮(NO)、前列腺素E2(PGE2)的产生,以及抑制LPS介导的炎症介质的表达的上调,如一氧化氮合酶(iNOS),环氧合酶-2(COX-2)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-12(IL-12)和肿瘤坏死因子-α(TNF-α)。

此外,在LPS刺激的BV2细胞中,EsA明显抑制核因子-κB p65的易位(NF-κB p65κ),通过阻断 IκB-α的磷酸化和降解。在LPS刺激的BV2细胞中,EsA还降低丝裂原活化蛋白激酶(MAPK)的磷酸化水平,以及抑制NOD样受体PYRIN结构域蛋白3(NLRP3)炎性小体介导的Caspase-1激活。同时,在原代培养的小胶质细胞中,EsA还降低了Aβ1-42诱导的IL-1和IL-6的产生。

研究人员认为,商陆皂苷甲可能是一个有希望治疗神经炎性疾病的药物。

原始出处:

Yang H, Chen Y,et al.Esculentoside A exerts anti-inflammatory activity in microglial cells.Int Immunopharmacol. 2017 Aug 23;51:148-157. doi: 10.1016/j.intimp.2017.08.014. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (27)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-11-10 jj000001
  3. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2018-07-19 yb6560
  5. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-09-03 137****4081

    文章很有创意.学习了.谢

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-08-31 流逝的青春

    学习了!谢谢分享.

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-08-30 往日如昨

    学习了谢谢分享

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sun May 27 13:03:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787313, encodeId=44ce1e8731399, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Nov 10 01:03:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745736, encodeId=eda21e4573654, content=<a href='/topic/show?id=93236698576' target=_blank style='color:#2F92EE;'>#炎性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66985, encryptionId=93236698576, topicName=炎性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=629135549792, createdName=vividelife, createdTime=Sun Feb 18 13:03:00 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996040, encodeId=95b0199604039, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 19 13:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717500, encodeId=cbcf1e1750040, content=<a href='/topic/show?id=1a47e436211' target=_blank style='color:#2F92EE;'>#神经炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74362, encryptionId=1a47e436211, topicName=神经炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=662f32423113, createdName=liye789132262, createdTime=Fri Jul 20 09:03:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788242, encodeId=b1e41e8824221, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Jan 01 05:03:00 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240083, encodeId=b138240083db, content=文章很有创意.学习了.谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLEZQLsqPsCbsOnBS1AERT05H5eKZXUPMd8o1fzdcmdLAGj7j0Z5ia7qvh5a4ziakicAQkKsFGwmJLA0/0, createdBy=3caa2052896, createdName=137****4081, createdTime=Sun Sep 03 20:01:12 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238875, encodeId=cf392388e515, content=学习了!谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Thu Aug 31 07:15:12 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238559, encodeId=f10323855992, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Aug 30 07:46:46 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238514, encodeId=4edf2385146b, content=学习了!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/24/26b17bef207f5a16bb76644d2b22859e.jpg, createdBy=799d1992408, createdName=流逝的青春, createdTime=Wed Aug 30 06:41:13 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-08-30 流逝的青春

    学习了!谢谢分享!

    0